grant

Enteric Pathogen Force of Infection among Children using Serology

Organization UNIVERSITY OF CALIFORNIA, SAN FRANCISCOLocation SAN FRANCISCO, UNITED STATESPosted 1 Jul 2021Deadline 30 Jun 2027
NIHUS FederalResearch GrantFY20250-11 years old0-4 weeks old2019 novel corona virus2019 novel coronavirus2019-nCoV7S Gamma GlobulinAIDS VirusAcquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome VirusAddressAgeAntibodiesAntibody ResponseAntigensArboviralArbovirusesArthropod-Borne VirusesAssayBenchmarkingBest Practice AnalysisBioassayBiological AssayBirthBloodBlood Reticuloendothelial SystemBlood SerumBlood TestsC jejuniC parvumC. jejuniC. parvumCOVID-19 virusCOVID19 virusCampylobacter jejuniCharacteristicsChildChild YouthChildren (0-21)ClinicalCoV-2CoV2ComplementComplement ProteinsCross InfectionCross Sectional AnalysisCross-Sectional AnalysesCross-Sectional StudiesCross-Sectional SurveyCryptosporidium parvumDataDengueDiarrheaDiseaseDisease Frequency SurveysDisorderE histolyticaE. histolyticaETECEcuadorEndamoeba histolyticaEnrollmentEntamoeba histolyticaEnteralEntericEnvironmentEpidemiologic MethodologyEpidemiologic MethodsEpidemiologic ResearchEpidemiologic StudiesEpidemiologic research methodologyEpidemiologic research methodsEpidemiological MethodsEpidemiological StudiesEpidemiological TechniquesEpidemiologyEpidemiology ResearchFailureFecesFrequenciesFundingGI microbiomeGeneralized GrowthGiardiaGoalsGrowthHIVHematologic TestsHematological TestsHematology TestingHeterogeneityHistoryHuman Immunodeficiency VirusesIgAIgGImmunoglobulin AImmunoglobulin GIncidenceInfant MortalityInfant Mortality TotalInfectionKineticsLAV-HTLV-IIILambliaLanguageLegal patentLong-term cohortLongitudinal StudiesLongitudinal cohortLow-resource areaLow-resource communityLow-resource environmentLow-resource regionLow-resource settingLymphadenopathy-Associated VirusMachine LearningMalariaMeasurementMeasuresMethodsMethods EpidemiologyMethods in epidemiologyModelingMolecularMonitorNIAIDNational Institute of Allergy and Infectious DiseaseNatureNewborn InfantNewbornsNorovirusNorwalk-like VirusesPaludismParturitionPatentsPlasmodium InfectionsPopulationPopulation DensityPublic HealthRecording of previous eventsResearchResearch SpecimenResolutionResource-constrained areaResource-constrained communityResource-constrained environmentResource-constrained regionResource-constrained settingResource-limited areaResource-limited communityResource-limited environmentResource-limited regionResource-limited settingResource-poor areaResource-poor communityResource-poor environmentResource-poor regionResource-poor settingRuralS entericaS. entericaSARS corona virus 2SARS-CO-V2SARS-COVID-2SARS-CoV-2SARS-CoV2SARS-associated corona virus 2SARS-associated coronavirus 2SARS-coronavirus-2SARS-related corona virus 2SARS-related coronavirus 2SARSCoV2Salmonella entericaSamplingSeriesSerologySerumSevere Acute Respiratory Coronavirus 2Severe Acute Respiratory Distress Syndrome CoV 2Severe Acute Respiratory Distress Syndrome Corona Virus 2Severe Acute Respiratory Distress Syndrome Coronavirus 2Severe Acute Respiratory Syndrome CoV 2Severe Acute Respiratory Syndrome-associated coronavirus 2Severe Acute Respiratory Syndrome-related coronavirus 2Severe acute respiratory syndrome associated corona virus 2Severe acute respiratory syndrome coronavirus 2Severe acute respiratory syndrome related corona virus 2SiteSourceSpecimenSurvey InstrumentSurveysTestingTimeTissue GrowthTransmissionUrbanizationVariantVariationVirus-HIVVisitWuhan coronavirusagesantibody based detectionantibody detectionbenchmarkburden of diseaseburden of illnesscognitive developmentcohortcomplementationcontinuous monitoringcoronavirus disease 2019 viruscoronavirus disease-19 virusdeath among infantsdeath in first year of lifedeath in infancydeath in infantsdemographicsdesigndesigningdetect antibodiesdiarrheal diseasediarrheal illnessdigestive tract microbiomedisease burdenenrollenteral infectionenteral pathogenenteric infectionenteric microbiomeenteric pathogenenteric pathogen infectionenteropathogenenteropathogen infectionenteropathogenic infectionenterotoxigenic E colienterotoxigenic E. colienterotoxigenic E.colienterotoxigenic Escherichia coliepidemiologicepidemiologic investigationepidemiologicalepidemiology studyfecal samplegastrointestinal microbiomegut microbiomegut-associated microbiomehCoV19historiesimmunogenimprovedinfant deathinfant demiseinfantile deathinfected with enteropathogeninsightintestinal biomeintestinal infectionintestinal microbiomeintestinal pathogenintestine infectionintestine pathogenkidslong-term studylongitudinal outcome studiesmachine based learningmortality in infantsmultiplex assaynCoV2newborn childnewborn childrenontogenypathogenpathogen exposurepopulation basedpublic health interventionresolutionsresponseserology surveillanceserology surveyserosurveillanceserosurveystoolstool samplestool specimentooltransmission processurban areaurban locationurban regionyoungster
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Enteric pathogen infections are a leading cause of the global disease burden, with the largest burden among
children in low-resource settings. Stool-based PCR methods have dramatically improved our ability to measure

enteric infections, but the challenge of collecting stool and need for near-continuous monitoring to detect many

globally important pathogens has thwarted broader use in large-scale surveillance. Large-scale, population-

based surveys now regularly collect blood to monitor transmission and burden of diseases such as HIV, malaria

and dengue. Broader testing of blood collected in such surveys with multiplex assays represents a new

opportunity to measure enteric pathogen transmission and burden. Antibody-based measures could complement

stool-based PCR testing because antibody responses remain elevated for many months after infection, thus

providing more information in studies with infrequent measurements. Our team has developed multiplex bead

assays that measure immunoglobulin G (IgG) response to diverse enteric pathogens. In preliminary studies we

have shown that IgG levels can be used to measure heterogeneity in enteric pathogen transmission between

populations. We have also shown the results generalize to pathogens that span taxa. In this application, we

propose to complete a series of studies that address key next steps to advance the seroepidemiology of enteric

pathogens in low-resource settings. We will conduct a longitudinal birth cohort in Ecuador that pairs high

resolution, multiplex stool-based PCR infection with longitudinal, multiplex IgG and IgA measurements. Our 17-

year research history at the site has documented substantial variation in enteric pathogen infection across a

rural-urban gradient, making it an ideal setting for the research. The cohort will enroll 600 children from three

sites across a rural-urban gradient, and measure them frequently from birth to 24 months. On the Luminex

platform, we will pair multiplex PCR assessment for 15 enteric pathogens with IgG and IgA assessment in a

multiplex bead assay that includes antigens to 7 enteric pathogens: Campylobacter jejuni, enterotoxigenic

Escherichia coli, Salmonella enterica, Giardia duodenalis, Cryptosporidium parvum, Entamoeba histolytica, and

norovirus. In Aim 1, we will use molecular and antibody-based measures to study force of infection of the enteric

pathogens across a rural-urban gradient. This will represent the first broad-based comparison of

seroepidemiologic measures against patent infection for enterics. In Aim 2, we will estimate enteric pathogen

force of infection by applying current-status models to population-based, cross-sectional serology surveys in the

region, and will benchmark the cross-sectional estimates against those obtained in the concurrent longitudinal

study. In Aim 3, we will study IgG and IgA kinetics following infection for each of the 7 pathogens, and develop

models to accurately predict recent infections and incidence from antibody levels measured in cross-sectional

serology surveys. Completion of these aims will result in generalizable seroepidemiologic methods that have the

potential to transform measurement of enteric pathogen transmission and burden in low-resource settings.

Grant Number: 5R01AI162867-05
NIH Institute/Center: NIH

Principal Investigator: Benjamin Arnold

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →